A single slide multiplex assay for the evaluation of classical Hodgkin lymphoma. Read more about A single slide multiplex assay for the evaluation of classical Hodgkin lymphoma.
Characterization of diverse immune cell types in single cancer tissue specimens using hyper-plexed in situ immunofluorescence staining technology Read more about Characterization of diverse immune cell types in single cancer tissue specimens using hyper-plexed in situ immunofluorescence staining technology
Hyper-plexed biomarker imaging using the MultiOmyx™ platform enables novel systems biology insights for the diagnosis and treatment of disease Read more about Hyper-plexed biomarker imaging using the MultiOmyx™ platform enables novel systems biology insights for the diagnosis and treatment of disease
Molecular profiling in determining diagnosis and prognosis of "early" myelodysplastic syndrome Read more about Molecular profiling in determining diagnosis and prognosis of "early" myelodysplastic syndrome
Molecular profiling in confirming the diagnosis of early myelodysplastic syndrome Read more about Molecular profiling in confirming the diagnosis of early myelodysplastic syndrome
Determining tumor load and biallelic mutation in patients with CALR mutation using peripheral blood plasma Read more about Determining tumor load and biallelic mutation in patients with CALR mutation using peripheral blood plasma
Deep sequencing of peripheral blood plasma DNA as a reliable test for confirming the diagnosis of MDS Read more about Deep sequencing of peripheral blood plasma DNA as a reliable test for confirming the diagnosis of MDS
Complete molecular risk stratification of de novo acute myeloid leukemia with intermediate cytogenetics using a nine-gene panel Read more about Complete molecular risk stratification of de novo acute myeloid leukemia with intermediate cytogenetics using a nine-gene panel
Diagnostic and prognostic scoring system for prostate cancer using urine and plasma biomarkers Read more about Diagnostic and prognostic scoring system for prostate cancer using urine and plasma biomarkers
Correlations between cytogenetic and molecular monitoring among patients with newly diagnosed chronic myeloid leukemia in chronic phase: post hoc analyses of the rationale and insight for Gleevec high-dose therapy study Read more about Correlations between cytogenetic and molecular monitoring among patients with newly diagnosed chronic myeloid leukemia in chronic phase: post hoc analyses of the rationale and insight for Gleevec high-dose therapy study